Effectiveness and Tolerability of Therapy With Once-Weekly Exenatide Versus Basal Insulin Among Injectable-Naive Patients With Type 2 Diabetes in a Real-World Setting in the United States

A propensity-matched cohort study compared injectable-naive patients with type 2 diabetes initiating exenatide once weekly (EQW) or basal insulin (BI), from 2012 through 2015, within a U.S. electronic health record database. A1C and weight were obtained as observed or multiply imputed values at base...

Descripción completa

Detalles Bibliográficos
Autores principales: Loughlin, Anita M., Qiao, Qing, Nunes, Anthony P., Ezzy, Stephen M., Yochum, Laura, Clifford, C. Robin, Gately, Robert V., Dore, David D., Seeger, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951230/
https://www.ncbi.nlm.nih.gov/pubmed/29773932
http://dx.doi.org/10.2337/ds16-0081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951230/
https://www.ncbi.nlm.nih.gov/pubmed/29773932
http://dx.doi.org/10.2337/ds16-0081

Ejemplares similares